About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02210039

Using Spectrally Encoded Confocal Microscopy (SECM) to Visualise the Esophagus Using an SECM Probe

The study is being done to test the feasibility and tolerability of a SECM imaging probe in patients with Barrett's Esophagus (BE). Subjects will undergo SECM probe imaging while they are under consc...

Lead sponsor: Massachusetts General Hospital•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Massachusetts General Hospital

Subjects with a previous diagnosis of Barrett's Esophagus will be recruited in the study and undergo SECM probe imaging while using conscious sedation, pulse oximetry and blood pressure monitoring. The probe will be inserted the predetermined required distance in the esophagus using a guide wire. Once the SECM imaging probe is in place, spiral SECM image data will be continuously collected over a pre-determined length (approximately 5cm).

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•A previous diagnosis of Barrett's Esophagus
•Patients must be over the age of 18
•Patient must be able to give informed consent

Exclusion Criteria

•Subjects with any history of intestinal strictures
•OR subjects with a history of prior GI surgery
•OR subjects with a history of intestinal Crohn's disease.

Related studies

RECRUITINGPhase 2

Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

NCT05745857 · Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, and more

A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

NCT06523374 · Barrett's Esophagus, Esophageal Adenocarcinoma

Australian Barrett's Cohort With Dysplasia and Early Cancer Study

NCT02198976 · Barrett's Esophagus

Barrett's Esophagus Related Neoplasia (BERN) Project

NCT00590239 · Barrett's Esophagus, Neoplasms, and more

CBAS180 De-escalation Study

NCT05740189 · Barrett's Esophagus, Ablation Therapy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 3, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment6

Start dateJun 2014

Last updatedApr 3, 2019

Condition

Barrett's Esophagus

Locations shown

Massachusetts General hospital

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 3, 2019Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions